The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer
- First Online:
- Cite this article as:
- Zogopoulous, G., Rothenmund, H., Eppel, A. et al. Hum Genet (2007) 121: 635. doi:10.1007/s00439-007-0361-z
- 102 Downloads
The P239S palladin variant has recently been suggested to play a role in hereditary pancreatic cancer. We estimated the contribution of the P239S variant, and surrounding sequence, to familial and early-onset pancreatic cancer. The P239S germline variant was identified in one of 84 high-risk cases and one of 555 controls. The case reported an elderly relative with pancreas cancer. We conclude that this variant does not appear to account for a significant fraction of hereditary or early-onset pancreas cancer.